Full name
RIVERMED SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
72.19.Z - Other research and experimental development on natural sciences and engineering
71.20.B - Other technical testing and analysis
72.11.Z - Research and experimental development on biotechnology
74.90.Z - Other professional, scientific and technical activities not elsewhere classified
86.10.Z - Hospital activities
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.23.Z - Dental practice activities
86.90.C - Nurses and midwives activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,2 | 0,1 | 0,3 | 210 |
Gross profit (loss) | 0,2 | 0,1 | 0,3 | 222,7 |
EBITDA | 0,2 | 0,1 | 0,4 | 173,1 |
Short time liabilities | 0 | 0,1 | 0,1 | -6,2 |
Other operating costs | 0 | 0 | 0 | 120,1 |
Equity capital | 0,2 | 0,2 | 0,5 | 95 |
Operating profit (EBIT) | 0,2 | 0,1 | 0,3 | 209,4 |
Assets | 0,3 | 0,3 | 0,5 | 56,5 |
Net profit (loss) | 0,2 | 0,1 | 0,3 | 226,3 |
Cash | 0,2 | 0,2 | 0,4 | 149,9 |
Net income from sale | 0,6 | 0,7 | 1,3 | 75,5 |
Liabilities and provisions for liabilities | 0,1 | 0,1 | 0,1 | -26,5 |
Working assets | 0,2 | 0,3 | 0,5 | 70,4 |
Other income costs | 0 | 0 | 0 | 51,3 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 85,5 | 38,2 | 63,9 | 25,7 |
Equity capital to total assets | 65,1 | 68,3 | 85,1 | 16,8 |
Gross profit margin | 27,4 | 13,8 | 25,5 | 11,7 |
EBITDA Margin | 32 | 18,1 | 28,1 | 10 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 23 | 35 | 19 | -16 |
Current financial liquidity indicator | 5.7166428565979 | 4.462257385253906 | 8.104350090026855 | 3,6 |
Net dept to EBITDA | -0.4507003426551819 | -0.7984472513198853 | -1.0440151691436768 | -0,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane